comparemela.com

Latest Breaking News On - San giuseppe vesuviano - Page 1 : comparemela.com

Svas Biosana S p A : Financial Statements at 31 December 2023 approved

PRESS RELEASE THE SHAREHOLDERS MEETING OF SVAS BIOSANA S.p.A. Approves the financial statements for the year ended 31 December 2023 .

San-giuseppe-vesuviano
Campania
Italy
Trentola
Somma-vesuviana
Casella-postale
Svas-biosana
Direzione-ed-uffici
Borsa-italiana
Articles-of-association
Company-articles-of-association
Statutory-auditors

Everything Netflix's Get Gotti Leaves Out About John Gotti

Netflix mob docuseries Get Gotti leaves some questions on the table. Thankfully, we have the answers.

Connecticut
United-states
Florida
Italy
Rockaway
New-jersey
Ozone-park
New-york
Palermo
Sicilia
Turkey
Southern-france

Svas Biosana S p A : The Board of Directors of SVAS Biosana approves the short-form consolidated half-yearly financial statements as at 30 june 2023 -September 27, 2023 at 05:38 am EDT

EBITDA Margin 12.6% Consolidated EBIT: €4.2 million - EBIT Margin 7.7% Consolidated Net Profit: €2.3 million .

Milan
Lombardia
Italy
Ukraine
Slovenia
Russia
Bolzano
Trentino-alto-adige
Croatia
Serbia
Somma-vesuviana
Campania

Svas Biosana S p A : Beginning of the second exercise period for SVAS Biosana

PRESS RELEASE BEGINNING OF THE SECOND EXERCISE PERIOD FOR SVAS BIOSANA WARRANTS 2021-2024 Somma Vesuviana 29 June.

Somma-vesuviana
Campania
Italy
Trentola
San-giuseppe-vesuviano
Svas-biosana
Monte-titoli
Somma-vesuviana-naples
Companies-register
Euronext-growth-milan
Second-exercise-period
Biosana-warrants

Svas Biosana S p A : Financial statements as at and for the year ended 31 December 2022 approved

PRESS RELEASE SVAS BIOSANA S.p.A. S ORDINARY SHAREHOLDERS MEETING Financial statements as at and for the year ended 31 December 2022. | May 17, 2023

Italy
Trentola
Campania
Somma-vesuviana
San-giuseppe-vesuviano
Somma-vesuviana-naples
Svas-biosana
Borsa-italiana
Lieto-vollaro
Companies-register
Euronext-growth-milan
Donatella-de-lieto-vollaro

vimarsana © 2020. All Rights Reserved.